GlassScriptPhysician profile
Amber D Whitear
NPI 1659589737
$3,428.16
in general payments reported to CMS, 2019-2025
36 companies · $575 in 2025
The $575 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $231 · 2021: $453 · 2022: $1,060 · 2023: $554 · 2024: $246 · 2025: $575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120 · Gift: $185 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,119.78 |
| Gift | $185.22 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,137.86 | 2019-2025 | Da Vinci Surgical System |
| Astellas Pharma US INC | $457.28 | 2019-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $263.87 | 2020-2025 | Myosure Tissue Removal Device |
| Abbvie INC. | $257.47 | 2019-2023 | Liletta |
| Bayer Healthcare Pharmaceuticals INC. | $136.77 | 2019-2025 | |
| Coloplast Corp | $121.97 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $86.29 | 2024-2025 | Gemtesa, Myfembree |
| Coopersurgical, INC. | $83.00 | 2019-2025 | Paragard T 380a |
| Evofem Biosciences, INC. | $68.54 | 2021-2023 | Phexxi |
| Organon LLC | $66.56 | 2023-2024 | Nexplanon |
| Biogen, INC. | $66.53 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $62.18 | 2021-2022 | |
| Medtronic, INC. | $59.97 | 2022 | |
| Innovation Technologies INC | $56.27 | 2025 | Irrisept |
| Therapeuticsmd, INC. | $55.80 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $41.57 | 2025 | Exparel |
| Axonics, INC. | $40.21 | 2022-2023 | Axonics, Bulkamid |
| Merck Sharp & Dohme LLC | $34.46 | 2019-2020 | |
| Exeltis, USA INC. | $32.70 | 2024-2025 | Slynd |
| Meditrina | $24.92 | 2025 | |
| Baxter Healthcare | $23.34 | 2022 | |
| Ascend Therapeutics US, LLC | $21.84 | 2019 | |
| Becton, Dickinson and Company | $20.71 | 2024 | Bd Surepath Collection Vial |
| Urovant Sciences INC | $18.75 | 2022 | |
| Eisai INC. | $18.60 | 2024 | |
| Ethicon US, LLC | $18.46 | 2025 | Vistaseal, Ethicon |
| Aspira Women'S Health INC | $18.14 | 2021 | |
| Agile Therapeutics, INC. | $17.51 | 2021 | |
| Pfizer INC. | $17.05 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $16.03 | 2025 | |
| Avion Pharmaceuticals | $14.85 | 2022 | |
| Gynesonics, INC. | $14.54 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Allergan, INC. | $14.49 | 2019 | |
| Shield Therapeutics INC | $13.76 | 2023 | Accrufer |
| Lupin INC. | $13.63 | 2019 | |
| Caldera Medical, INC | $12.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Whitear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.